University of the Incarnate Word

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, University of the Incarnate Word sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials none currently recruiting 10 completed top decile by trial count

University of the Incarnate Word: 11 sponsored US clinical trials, none currently recruiting.

University of the Incarnate Word sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 10 completed. The most-studied condition in this pipeline is Contact Lens Discomfort, with 1 trials.

Top-decile sponsor footprint

University of the Incarnate Word ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

11 total, page 1 of 1

ACTIVE NOT RECRUITING NA

Meibomian Gland Dysfunction Management

NCT03652337
COMPLETED NA

The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression

NCT05713981
COMPLETED NA

Athlete Whey Protein Sensitivity: Prevalence and Performance

NCT05482997
COMPLETED NA

The Outcome of Sports Vision Training on Collegiate Softball Players

NCT05990036
COMPLETED NA

Impact of Color Correcting Lenses on Color Vision Deficiency

NCT05463016
COMPLETED NA

Effectiveness of Blood Flow Restriction During Aerobic Cycling

NCT04808869
COMPLETED NA

Meibomian Gland Dysfunction Management With ZEST Protocol

NCT03968731
COMPLETED NA

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

NCT03393637
COMPLETED NA

Impact of Dark Chocolate on Visual Performance

NCT03326934
COMPLETED NA

Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis

NCT02952079
COMPLETED NA

Impact of Pilates on Running Mechanics

NCT04815980

Therapeutic Areas

Contact Lens Discomfort 1
Meibomian Gland Dysfunction 1

How the University of the Incarnate Word archive is shaped

11 indexed studies, none listed as recruiting (0% open); 10 completed (91%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Contact Lens Discomfort (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

University of the Incarnate Word: archived-pipeline peers nationwide

Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

University of the Incarnate Word sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share University of the Incarnate WordAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiome10xBio22nd Century Group23andMe3-C Institute for Social Development
University of the Incarnate Word sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of the Incarnate Word sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of the Incarnate Word page

11 registered trials is a research-attention snapshot, not an endorsement of University of the Incarnate Word or any single study.

  • None of University of the Incarnate Word's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Contact Lens Discomfort is the condition University of the Incarnate Word studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Contact Lens Discomfort trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of the Incarnate Word pipeline card: 11 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.